Cargando…
Efficacy of Xuebijing Injection for Sepsis (EXIT-SEP): protocol for a randomised controlled trial
INTRODUCTION: Sepsis is a major challenge with high incidence and is associated with high mortality worldwide. Current management of sepsis remains mainly supportive except for treatment with antibiotics. Both basic research and clinical investigation have shown that the Chinese herbal-derived thera...
Autores principales: | Liu, Songqiao, Yao, Chen, Zhang, Junhua, Yang, Yi, Qiu, Haibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720249/ https://www.ncbi.nlm.nih.gov/pubmed/31467049 http://dx.doi.org/10.1136/bmjopen-2018-028664 |
Ejemplares similares
-
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol
por: Kotsaki, Antigone, et al.
Publicado: (2022) -
Effects of intravenous sivelestat sodium on prevention of acute respiratory distress syndrome in patients with sepsis: study protocol for a double-blind multicentre randomised controlled trial
por: Ma, Shaolei, et al.
Publicado: (2023) -
Adjuvant Lipoic acid Injection in Sepsis treatment in China (ALIS study): protocol for a randomised, single-blind, placebo-controlled trial
por: Hu, Linhui, et al.
Publicado: (2023) -
Fluids in Sepsis and Septic Shock (FISSH): protocol for a pilot randomised controlled trial
por: Rochwerg, Bram, et al.
Publicado: (2017) -
β-Blockers in sepsis: protocol for a systematic review and meta-analysis of randomised control trials
por: Duan, Erick H, et al.
Publicado: (2016)